The study covers a detailed analysis segmented by key business segments i.e. by type (Insulin Needle-Free Injection Device , Auxin Needle-Free Injection Device and Other ) , by application (Vaccine Delivery, Insulin Delivery, Pain Management, Pediatric Injections and Others) and major geographies.
What is Needle Free Drug Delivery Devices?
Needle Free Drug Delivery Devices are used to delivers the vaccine into the muscle without need of needles. This eliminates the risk of reusing needles or needle stick injuries. These devices are easy-to-administer and minimizes injection-associated fear and anxiety for the patient and provider. As per sources, ~425 million people are effected by diabetes globally. Nearly 20% of North American population are diagnosed with diabetes and are dependent on the daily administration of insulin. The popularity of self-injectable medications is encouraging patients to adopt self-administered medications to reduce healthcare expense. Hence, this is leading to increase the demand for needle free drug delivery devices.
The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Needle Free Drug Delivery Devices market analysis report suggests strategies Players can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Players, including:
- 3M (United States)
- Bioject Medical Technologies (United States)
- Eternity Healthcare (Hong Kong)
- Crossject (France)
- National Medical Products Inc (United States)
- Valeritas (United States)
- Injex Pharma AG (Germany)
- Neo Laboratories (India)
- PharmaJet, Inc. (United States)
- Medical International Technology (Canada)
- Bespak Europe Ltd. (United Kingdom)
- Zogenix (United States)
- European Pharma Group (InsuJet) (Netherlands)
- Antares Pharma (United States)
- D'Antonio Consultants International (United States)
- PenJet Corporation (United States)
- Beijing QS Medical Technology (China)
On April 2020, Zealand Pharma acquired Valeritas Holdings, Inc. for USD 23 million. With this acquisition, Zealand Pharma acquired the rights to offer the Valeritas’ V-Go wearable insulin delivery device that was developed to help people manage their diabetes.
The global needle free drug delivery devices market is highly competitive and consists of a several manufacturers at the global and regional levels who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for the market growth.
Trend for Self-administration of Drugs
- High Cost Of Needle Free Drug Delivery Devices
Demand for Reducing Risks Such as Infection and Pain Due to Use of Traditional Needle Delivery Methods and Increasing Demand For Pain-Free Delivery Of Drugs For Children
Key highlights of the Global Needle Free Drug Delivery Devices market Study:
CAGR of the market during the forecast period 2019-2025
Detailed information on factors that will accelerate the growth of the Needle Free Drug Delivery Devices market for the next five years.
Forecast of the Global Needle Free Drug Delivery Devices market size and its contribution to the parent market by type, application and by country.
Insights on upcoming trends and changes in consumer behaviour
Uncovering markets competitive landscape and in-depth information on various Players
Comprehensive information about factors that will challenge the growth of Needle Free Drug Delivery Devices Players
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Needle Free Drug Delivery Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Needle Free Drug Delivery Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Needle Free Drug Delivery Devices Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.